Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2022 16:30 ET | Source: Celsion Corporation

Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct...
April 01, 2022 08:00 ET | Source: Celsion Corporation

Celsion Corporation Reported Cash Position of $56.9 million at December 31, 2021

LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced...
March 24, 2022 09:00 ET | Source: Celsion Corporation

Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022

LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
June 04, 2021 10:11 ET | Source: Celsion CORP

CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING

49% of Shares Voted, Quorum Not Established To Hold Annual Meeting Polls Remain Open Stockholders Holding Unvoted Proxies Are Strongly Encouraged to Vote Their Shares LAWRENCEVILLE, N.J.,...
April 20, 2021 12:00 ET | Source: Oncotelic Therapeutics, Inc.

ONCOTELIC THERAPEUTICS, INC. ANNOUNCES POSITIVE TOP LINE DATA FOR ARTI-19 CLINICAL TRIAL EVALUATING PULMOHEAL™ VERSUS COVID-19.

AGOURA HILLS, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and...
March 31, 2021 08:00 ET | Source: Celsion CORP

CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING

LAWRENCEVILLE, NJ, March 31, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...
November 19, 2020 09:50 ET | Source: FluroTech Ltd.

FluroTech Announces Its Safe Air Travel Product Solution

CALGARY, Alberta, Nov. 19, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
November 18, 2020 08:30 ET | Source: FluroTech Ltd.

FluroTech Announces Stadium and Arena Product Solution

CALGARY, Alberta, Nov. 18, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
November 17, 2020 08:00 ET | Source: FluroTech Ltd.

FluroTech Announces Stadium and Arena Product Solution

CALGARY, Alberta, Nov. 17, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
November 12, 2020 09:00 ET | Source: FluroTech Ltd.

FluroTech Announces Joint Venture SARS-CoV2 Test Method Optimization

CALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2...